Search results
Results from the WOW.Com Content Network
Clinician Administered PTSD Scale (CAPS) Daily Assessment of Symptoms – Anxiety; Generalized Anxiety Disorder 7 (GAD-7) [4] [5] Hamilton Anxiety Scale (HAM-A) [6] [7] Hospital Anxiety and Depression Scale; Panic and Agoraphobia Scale (PAS) Panic Disorder Severity Scale (PDSS) PTSD Symptom Scale – Self-Report Version; Screen for child ...
At steady state, the systemic exposure for armodafinil is 1.8 times the exposure observed after a single dose. The concentration-time profiles of the (R)-(−)-enantiomer following a single dose of 50 mg Nuvigil or 100 mg Provigil (modafinil being a 1:1 mixture of (R)-(−)- and (S)-(−)- enantiomers
Modafinil, sold under the brand name Provigil among others, is a central nervous system (CNS) stimulant and eugeroic (wakefulness promoter) medication used primarily to treat narcolepsy, [3] [8] [15] a sleep disorder characterized by excessive daytime sleepiness and sudden sleep attacks. [16]
For example, a normed personality scale can help psychologists understand how some people are high in negative affectivity (NA) and others are low or intermediate in NA. With many psychoeducational tests, test norms allow educators and psychologists obtain an age- or grade-referenced percentile rank, for example, in reading achievement.
[2] The SUD-level was developed by Joseph Wolpe in 1969. [3] It has been used in cognitive-behavioral treatments for anxiety disorders (e.g. exposure practices and hierarchy) and for research purposes. There is no hard and fast rule by which a patient can self assign a SUDS rating to his or her disturbance or distress, hence the name subjective.
Stelazine (trifluoperazine) – an antipsychotic used in the treatment of psychotic disorders, anxiety, and nausea caused by chemotherapy [2] Strattera (atomoxetine) – a non-stimulant medication used to treat ADHD; Suboxone (buprenorphine/naloxone) - a partial opioid agonist used in the treatment of opioid use disorder
The Daily Assessment of Symptoms – Anxiety (DAS-A) questionnaire was specifically developed to detect reduction of anxiety symptoms in patients with generalized anxiety disorder (GAD) during the first week of treatment. [1] It is also meant to help those suffering from certain symptoms identify and recognize that they are experiencing anxiety.
Anxiety present questions represent the presence of anxiety in a statement like “I feel worried.” More examples from the STAI on anxiety absent and present questions are listed below. Each measure has a different rating scale. The 4-point scale for S-anxiety is as follows: 1.) not at all, 2.) somewhat, 3.) moderately so, 4.) very much so.